City of Hope Comprehensive Cancer Center
Duarte, California, 91010-3000, United States
NCT Number: NCT00823667
RATIONALE: Palliative care may be more effective than standard care in improving quality of life and symptoms in patients with lung cancer.
PURPOSE: This clinical trial is studying the effects of palliative care on quality of life and symptom control in patients with stage I, stage II, or stage IIIA non-small cell lung cancer that can be removed by surgery.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Duarte, California, 91010-3000, United States
OBJECTIVES:
OUTLINE: Patients assigned to 1 of 2 groups.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Palliative care intervention at weeks 3,4,5 and 6 post study enrollment
Occurs at 1 year post study enrollment
Occurs at baseline, 6 weeks, 12 weeks, 24 weeks, 36 weeks and 52 weeks post study enrollment
Occurs at baseline, 6 weeks, 12 weeks, 24 weeks, 36 weeks and 52 weeks post study enrollment
Occurs at baseline, 6 weeks, 12 weeks, 24 weeks, 36 weeks and 52 weeks post study enrollment
Occurs at baseline, 6 weeks, 12 weeks, 24 weeks, 36 weeks and 52 weeks post study enrollment
Time frame: 1 year after study enrollment
Time frame: 1 year after study enrollment
Time frame: 1 year after study enrollment
Time frame: 1 year after study enrollment
Time frame: Week 12 after study enrollment
City of Hope Medical Center
Other
Palliative Care for Quality of Life and Symptom Concerns in Early Stage Lung Cancer
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT04939324
Bronchial Neoplasms, Carcinoma, Bronchogenic
Limoges, France
View Trial DetailsNCT04262856
Bronchial Neoplasms, Carcinoma, Bronchogenic
Birmingham, Alabama, United States
View Trial DetailsNCT01421953
Bronchial Neoplasms, Carcinoma, Bronchogenic
Bordeaux, France
View Trial DetailsNCT05928299
Bronchial Neoplasms, Carcinoma, Bronchogenic
Guangzhou, Guangdong, China
View Trial Details